Clinical features and treatment of infection due to mycobacterium fortuitum/chelonae complex.
McFarland
E J
EJ
Division of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver.
Kuritzkes
D R
DR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000209:etiology; D004352:Drug Resistance, Microbial; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D016926:Mycobacterium chelonae / Q000187:drug effects; D009170:Nontuberculous Mycobacteria / Q000187:drug effects; D014382:Tuberculosis, Cutaneous / Q000209:etiology; D014397:Tuberculosis, Pulmonary / Q000209:etiology
D000900:Anti-Bacterial Agents